Genuinely asking, not being difficult. Everyone in c/semaglutide repeats that dual agonist is important. I believe it, but I have never seen anyone show why, and when I…
u/line_petrov
Contributes reviews on supplier material. Based in Hyderabad.
member · joined 12 Mar 2025
Overview — page 3 of 5
comment on does Zepbound actually matter or is it forum lore at this point in c/tirzepatide · 74 points · 9 months ago
the 15mg is the top of the pen, not the required dose
comment on does Zepbound actually matter or is it forum lore at this point in c/tirzepatide · 384 points · 9 months ago
the fatigue from tirz is different, not necessarily worse
comment on nobody warned me about sulphur burps and I would have liked the warning in c/tirzepatide · 415 points · 10 months ago
Mechanistically the bit that matters is GIP. It explains most of the early profile and a decent chunk of the outcome.
comment on three years of sulphur burps threads, summarised so you do not have to read them in c/sideeffects · 264 points · 10 months ago
Did the reflux start before or after the dose increase?
comment on genuine question about dual agonist that I am slightly embarrassed to ask in c/tirzepatide · 50 points · 10 months ago
Disagree. What you are describing is consistent with 15mg, not with what you concluded.
comment on anyone else notice BPC-157 kicking in around week 54 in c/bpc157 · 1 points · 10 months ago
Which country? Half the answers in this thread only apply in Denmark.
comment on copay — 3 things I got wrong before I got it right in c/insurancefights · 9 points · 10 months ago
Mechanistically the bit that matters is formulary. It explains most of the early profile and a decent chunk of the outcome.
comment on [Meta] the reflux rule is doing its job and people should stop complaining in c/sideeffects · 131 points · 11 months ago
constipation is real, boring, and fixable
comment on am I the only one who found regulatory harder than the injections in c/bpc157 · 7 points · 11 months ago
Respectfully this is a sample of one presented as a finding.
comment on help me understand tendon, I have read the wiki twice in c/bpc157 · 0 points · 11 months ago
handlers in the community are rare and cautious
comment on switched from 0.25mg to 1.7mg and the muscle cramps got better, not worse in c/sideeffects · 1 points · 12 months ago
Slight fix: the number was 97.4, not 97.2.
Adding to this: heart rate is doing more work than the comment implies.
comment on week 11 check-in — 21kg down, injection-site soreness manageable, one thing confusing me in c/bpc157 · 9 points · 1 year ago
the tendon rodent evidence is solid, human evidence is not
comment on reflux — my 12-week log, condensed into one table in c/sideeffects · 69 points · 1 year ago
sulphur burps are disgusting but not dangerous, 19 weeks and they stopped
comment on step therapy — my 7-week log, condensed into one table in c/insurancefights · 65 points · 1 year ago
The confident tone is doing a lot of work that the evidence is not.
comment on [Vendor] QST order #2 — Denmark, 37 days, no drama, receipts inside in c/bpc157 · 155 points · 1 year ago
near-zero controlled human data, full stop
comment on heart rate — 6 things I got wrong before I got it right in c/sideeffects · 21 points · 1 year ago
ask your actual doctor, not us
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
comment on genuine question about regulatory that I am slightly embarrassed to ask in c/bpc157 · 17 points · 1 year ago
Week 2 for me and the honest summary is: 39kg down, nausea manageable, and I have thought about food maybe four times today.
comment on stalled for 4 weeks at 2.4mg and I refuse to panic this time in c/sideeffects · 1.3k points · 1 year ago
the muscle cramps passes. i promise. not medical advice.
comment on [Question] how do you actually verify external review in c/insurancefights · 10 points · 1 year ago
Crossposting this to c/coldchain because the people who need it are not reading this community.
Adding to this: formulary is doing more work than the comment implies.